Regenerative Medical Solutions Overview
- Year Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.8M
- Investors
-
5
Regenerative Medical Solutions General Information
Description
Operator of a regenerative biotechnology company intended for cellular-level diabetes treatment. The company's platform develops stem cell therapies that transform pluripotent cells into insulin-producing islet cells, avoiding immunosuppressive drugs and embryo-derived materials, enabling healthcare providers and diabetic patients to access a functional, ethical, and potentially curative alternative to insulin injections and organ-dependent transplants.
Contact Information
Website
www.regenmedsolutions.comCorporate Office
- 505 South Rosa Road
- Suite 26
- Madison, WI 53719
- United States
Corporate Office
- 505 South Rosa Road
- Suite 26
- Madison, WI 53719
- United States
Regenerative Medical Solutions Timeline
Regenerative Medical Solutions Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Grant | 09-Oct-2025 | $1.8M | Completed | Generating Revenue | ||
| 8. Later Stage VC | 28-Aug-2023 | Completed | Generating Revenue | |||
| 7. Grant | 23-Sep-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 14-Aug-2018 | Completed | Generating Revenue | |||
| 5. Grant | 16-Sep-2016 | Completed | Generating Revenue | |||
| 4. Seed Round | 07-Nov-2014 | Completed | Generating Revenue | |||
| 3. Grant | 18-Sep-2014 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 20-Jun-2013 | $850K | $1.85M | Completed | Generating Revenue | |
| 1. Capitalization | 01-Jan-2012 | $1M | $1M | Completed | Startup |
Regenerative Medical Solutions Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Regenerative Medical Solutions Comparisons
Industry
Financing
Details
Regenerative Medical Solutions Competitors (56)
One of Regenerative Medical Solutions’s 56 competitors is Neurona Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurona Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Cellaion | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| Sernova Biotherapeutics | Corporation | Mississauga, Canada | ||||
| Histogen | Formerly VC-backed | San Ramon, CA | ||||
| Seraxis | Venture Capital-Backed | Germantown, MD |
Regenerative Medical Solutions Patents
Regenerative Medical Solutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160230225-A1 | Markers for differentiation of stem cells into differentiated cell populations | Active | 22-Jan-2015 | ||
| US-20180080077-A1 | Markers for differentiation of stem cells into differentiated cell populations | Inactive | 22-Jan-2015 | ||
| US-9828634-B2 | Markers for differentiation of stem cells into differentiated cell populations | Active | 22-Jan-2015 | ||
| WO-2016118824-A1 | Markers for differentiation of stem cells into differentiated cell populations | Inactive | 22-Jan-2015 | ||
| US-10138466-B2 | Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells | Active | 19-Sep-2014 | C12N5/0676 |
Regenerative Medical Solutions Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| Mission Cure Capital | Impact Investing | Minority | ||
| U.S. Department of Health and Human Services | Government | |||
| National Institute of Diabetes and Digestive and Kidney Diseases | Government | |||
| Wisconsin Economic Development | Government | Minority |
Regenerative Medical Solutions FAQs
-
When was Regenerative Medical Solutions founded?
Regenerative Medical Solutions was founded in 2012.
-
Where is Regenerative Medical Solutions headquartered?
Regenerative Medical Solutions is headquartered in Madison, WI.
-
What industry is Regenerative Medical Solutions in?
Regenerative Medical Solutions’s primary industry is Biotechnology.
-
Is Regenerative Medical Solutions a private or public company?
Regenerative Medical Solutions is a Private company.
-
What is Regenerative Medical Solutions’s current revenue?
The current revenue for Regenerative Medical Solutions is .
-
How much funding has Regenerative Medical Solutions raised over time?
Regenerative Medical Solutions has raised $8.18M.
-
Who are Regenerative Medical Solutions’s investors?
National Institutes of Health, Mission Cure Capital, U.S. Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, and Wisconsin Economic Development have invested in Regenerative Medical Solutions.
-
Who are Regenerative Medical Solutions’s competitors?
Neurona Therapeutics, Cellaion, Sernova Biotherapeutics, Histogen, and Seraxis are some of the 56 competitors of Regenerative Medical Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process